{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T13:20:03Z","timestamp":1790860803869,"version":"4.1.0"},"reference-count":0,"publisher":"Oxford University Press (OUP)","issue":"90001","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2003,5,1]]},"DOI":"10.1093\/jac\/dkg209","type":"journal-article","created":{"date-parts":[[2003,4,16]],"date-time":"2003-04-16T12:28:58Z","timestamp":1050496138000},"page":"21-27","source":"Crossref","is-referenced-by-count":71,"title":["Adverse drug reactions: implications for the development of fluoroquinolones"],"prefix":"10.1093","volume":"51","author":[{"given":"P.","family":"Ball","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/51\/suppl_1\/21\/7502997\/dkg209.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,24]],"date-time":"2017-08-24T09:30:14Z","timestamp":1503567014000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article-lookup\/doi\/10.1093\/jac\/dkg209"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,5,1]]},"references-count":0,"journal-issue":{"issue":"90001"},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkg209","relation":{},"ISSN":["1460-2091"],"issn-type":[{"value":"1460-2091","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,5,1]]}}}